A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Clinical trial NCT07454382 · RECRUITING
Trial details
- NCT number
- NCT07454382
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2029-08-27
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.